Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 09, 2022

SELL
$2.11 - $4.06 $114,995 - $221,269
-54,500 Closed
0 $0
Q1 2022

May 09, 2022

BUY
$2.73 - $11.94 $10,647 - $46,566
3,900 Added 7.71%
54,500 $149,000
Q4 2021

Feb 08, 2022

BUY
$11.49 - $22.0 $195,330 - $374,000
17,000 Added 50.6%
50,600 $581,000
Q2 2021

Aug 06, 2021

BUY
$17.81 - $27.48 $60,553 - $93,432
3,400 Added 11.26%
33,600 $756,000
Q4 2020

Feb 05, 2021

BUY
$20.81 - $30.55 $628,462 - $922,610
30,200 New
30,200 $756,000

Others Institutions Holding ANNX

About Annexon, Inc.


  • Ticker ANNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,617,700
  • Market Cap $249M
  • Description
  • Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...
More about ANNX
Track This Portfolio

Track Swiss National Bank Portfolio

Follow Swiss National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.